Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, December 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 3,894 followers.

New from #wellcometrust https://t.co/ZE8fgVblCf Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging

20 Apr 2019

Reply Repost Favourite

New from #CR_UK https://t.co/ZE8fgVblCf Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging

20 Apr 2019

Reply Repost Favourite

New from #breastcancernow https://t.co/ZE8fgUTKdF Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging

19 Apr 2019

Reply Repost Favourite

Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging. https://t.co/dDeb87C2CL

08 Dec 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.